47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
73.12.B - Advertising through mass media
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,6 | 1,1 | 1,1 | -4,8 |
Gross profit (loss) | 0,9 | 1,2 | 1,1 | -7,9 |
EBITDA | 1 | 1,3 | 1,1 | -11,2 |
Short time liabilities | 1,9 | 1,9 | 1,7 | -11,8 |
Other operating costs | 0 | 0 | 0 | -63,9 |
Equity capital | 1,3 | 1,8 | 1,7 | -4,8 |
Operating profit (EBIT) | 0,9 | 1,2 | 1,1 | -7,9 |
Assets | 3,4 | 3,9 | 3,6 | -6,8 |
Net profit (loss) | 0,9 | 1,2 | 1,1 | -7,9 |
Cash | 1,3 | 1,8 | 1,3 | -25,5 |
Liabilities and provisions for liabilities | 2,1 | 2,1 | 1,9 | -8,5 |
Net income from sale | 15,2 | 17 | 18,3 | 7,8 |
Working assets | 3,2 | 3,8 | 3,5 | -5,9 |
Other income costs | 0,3 | 0,1 | 0 | -87,9 |
Depreciation | 0,1 | 0,1 | 0 | -53,3 |
% | % | % | p.p. | |
Profitability of capital | 67,7 | 67,2 | 65 | -2,2 |
Equity capital to total assets | 38,4 | 45,4 | 46,4 | 1 |
Gross profit margin | 5,9 | 7 | 6 | -1 |
EBITDA Margin | 6,6 | 7,6 | 6,2 | -1,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 46 | 42 | 34 | -8 |
Current financial liquidity indicator | 1.6686917543411255 | 1.932873249053955 | 2.0617127418518066 | 0,2 |
Net dept to EBITDA | -1.0917290449142456 | -1.341124176979065 | -1.166130542755127 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane